Area-based disparities in non-small-cell lung cancer survival
DOI:
https://doi.org/10.2340/1651-226X.2024.27507Keywords:
lung cancer, disparity, rural and urban areas, non-small cell lung cancerAbstract
Background: In the Nordic countries, universal healthcare access has been effective in reducing socioeconomic disparities in non-small-cell lung cancer (NSCLC) management. However, other factors, such as proximity to healthcare facilities, may still affect access to care. This study aimed at investigating the influence of residential area on NSCLC survival.
Methods: This population-based study utilized hospital records to identify NSCLC patients who underwent their initial treatment at Vaasa Central Hospital between January 1, 2016, and December 31, 2020. Patients were categorized based on their postal codes into urban areas (≤50 km from the hospital) and rural areas (>50 km from the hospital). Survival rates between these two groups were compared using Cox regression analysis.
Results: A total of 321 patients were included in the study. Patients residing in rural areas (n = 104) exhibited poorer 12-month survival rates compared to their urban counterparts (n = 217) (unadjusted Hazard Ratio [HR]: 1.38; 95% Confidence Interval [CI]: 1.01–1.89; p = 0.042). After adjusting for factors such as performance status, frailty, and stage at diagnosis in a multivariate Cox regression model, the adjusted HR increased to 1.47 (95% CI: 1.07–2.01; p = 0.017) for patients living in rural areas compared to those in urban areas.
Interpretation: The study findings indicate that the distance to the hospital is associated with increased lung cancer mortality. This suggests that geographical proximity may play a crucial role in the disparities observed in NSCLC survival rates. Addressing these disparities should involve strategies aimed at improving healthcare accessibility, particularly for patients residing in rural areas, to enhance NSCLC outcomes and reduce mortality.
Downloads
References
Larønningen S, Ferlay J, Beydogan H, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 9.2 (23.06.2022). Association of the Nordic Cancer Registries. Cancer Registry of Norway; 2023 [cited 2023 Mar 15]. Available from: https://nordcan.iarc.fr/en
Cancer Statistics. Syöpärekisteri. [cited 2022 Jul 22]. Available from: https://cancerregistry.fi/statistics/cancer-statistics/
Crowell RE, Goetz T, Wiggins C, Magana E. Regional disparities in treatment and survival of early stage non-small cell lung cancer. Ethn Dis. 2007;17(2):358–64.
Johnson AM, Hines RB, Johnson JA, Bayakly AR. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Lung Cancer. 2014;83(3):401–7.
https://doi.org/10.1016/j.lungcan.2014.01.008 DOI: https://doi.org/10.1016/j.lungcan.2014.01.008
Pozet A, Westeel V, Berion P, et al. Rurality and survival differences in lung cancer: a large population-based multivariate analysis. Lung Cancer. 2008;59(3):291–300.
https://doi.org/10.1016/j.lungcan.2007.08.039 DOI: https://doi.org/10.1016/j.lungcan.2007.08.039
Bonett A, Roder D, Esterman A. Determinants of case survival for cancers of the lung, colon, breast and cervix in South Australia. Med J Aust. 1984;141(11):705–9.
https://doi.org/10.5694/j.1326-5377.1984.tb113226.x DOI: https://doi.org/10.5694/j.1326-5377.1984.tb113226.x
Rybojad P, Dłuski D, Rybojad B, et al. Urban vs. rural patients. Differences in stage and overall survival among patients treated surgically for lung cancer. Ann Agric Environ Med. 2013;20(1):101–5.
Åsli LM, Myklebust TÅ, Kvaløy SO, et al. Factors influencing access to palliative radiotherapy: a Norwegian population-based study. Acta Oncol. 2018;57(9):1250–8.
https://doi.org/10.1080/0284186X.2018.1468087 DOI: https://doi.org/10.1080/0284186X.2018.1468087
Sjöström O, Dahlin AM, Silander G, Syk I, Melin B, Hellquist BN. Travel time to care does not affect survival for patients with colorectal cancer in northern Sweden: a data linkage study from the Risk North database. PLoS One. 2020;15(8):e0236799.
https://doi.org/10.1371/journal.pone.0236799 DOI: https://doi.org/10.1371/journal.pone.0236799
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55. DOI: https://doi.org/10.1097/00000421-198212000-00014
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.
https://doi.org/10.1503/cmaj.050051 DOI: https://doi.org/10.1503/cmaj.050051
Lung Cancer. Current care guidelines. Working group set up by the Finnish Medical Society Duodecim and the Finnish Respiratory Society board, and the Finnish Society for Oncology. Helsinki: The Finnish Medical Society Duodecim; 2017 [cited 2022 Apr 05]. Available from: https://www.kaypahoito.fi/
Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020;20:393.
https://doi.org/10.1186/s12877-020-01801-7 DOI: https://doi.org/10.1186/s12877-020-01801-7
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
https://doi.org/10.1016/0021-9681(87)90171-8 DOI: https://doi.org/10.1016/0021-9681(87)90171-8
Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203.
https://doi.org/10.1016/j.chest.2016.10.010 DOI: https://doi.org/10.1016/j.chest.2016.10.010
Paakkola NM, Lindqvist J, Jekunen A, Sihvo E, Johansson M, Andersén H. Impact of sex and age on adherence to guidelines in non-small cell lung cancer management. Cancer Treat Res Commun. 2023;34:100675.
https://doi.org/10.1016/j.ctarc.2022.100675 DOI: https://doi.org/10.1016/j.ctarc.2022.100675
Lindqvist J, Jekunen A, Sihvo E, Johansson M, Andersén H. Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients. Lung Cancer. 2022;171:9–17.
https://doi.org/10.1016/j.lungcan.2022.07.006 DOI: https://doi.org/10.1016/j.lungcan.2022.07.006
Bhatia S, Landier W, Paskett ED, et al. Rural–Urban disparities in cancer outcomes: opportunities for future research. J Natl Cancer Inst. 2022;114(7):940–52.
https://doi.org/10.1093/jnci/djac030 DOI: https://doi.org/10.1093/jnci/djac030
Odahowski CL, Zahnd WE, Eberth JM. Challenges and opportunities for lung cancer screening in rural America. J Am Coll Radiol. 2019;16(4 Pt B):590–5.
https://doi.org/10.1016/j.jacr.2019.01.001 DOI: https://doi.org/10.1016/j.jacr.2019.01.001
Liff JM, Chow WH, Greenberg RS. Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening. Cancer. 1991;67(5):1454–9.
https://doi.org/10.1002/1097-0142(19910301)67:5<1454::aid-cncr2820670533>3.0.co;2-k DOI: https://doi.org/10.1002/1097-0142(19910301)67:5<1454::AID-CNCR2820670533>3.0.CO;2-K
Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J. Rural and urban differences in stage at diagnosis of colorectal and lung cancers. Br J Cancer. 2001;84(7):910–4.
https://doi.org/10.1054/bjoc.2000.1708 DOI: https://doi.org/10.1054/bjoc.2000.1708
Jong KE, Smith DP, Yu XQ, O’Connell DL, Goldstein D, Armstrong BK. Remoteness of residence and survival from cancer in New South Wales. Med J Aust. 2004;180(12):618–22.
https://doi.org/10.5694/j.1326-5377.2004.tb06123.x DOI: https://doi.org/10.5694/j.1326-5377.2004.tb06123.x
Keskimaki I, Tynkkynen LK, Reissell E, et al. Finland: health system review. Health Syst Transit. 2019;21(2):1–166.
Kotavaara O, Nivala A, Lankila T, Huotari T, Delmelle E, Antikainen H. Geographical accessibility to primary health care in Finland – grid-based multimodal assessment. Appl Geogr. 2021;136:102583.
https://doi.org/10.1016/j.apgeog.2021.102583 DOI: https://doi.org/10.1016/j.apgeog.2021.102583
Ministry of Social Affairs and Health. Development of cancer treatment in 2010–2020. Working group report (In Finnish). Rep Ministry Social Affairs Health. 2010;6:1–92.
Logan CD, Feinglass J, Halverson AL, et al. Rural-urban survival disparities for patients with surgically treated lung cancer. J Surg Oncol. 2022;126(7):1341–9.
https://doi.org/10.1002/jso.27045 DOI: https://doi.org/10.1002/jso.27045
Ray MA, Faris NR, Derrick A, Smeltzer MP, Osarogiagbon RU. Rurality, stage-stratified use of treatment modalities, and survival of non-small cell lung cancer. Chest. 2020;158(2):787–96.
https://doi.org/10.1016/j.chest.2020.04.042 DOI: https://doi.org/10.1016/j.chest.2020.04.042
Gardner B, Doose M, Sanchez JI, Freedman AN, de Moor JS. Distribution of genomic testing resources by oncology practice and rurality: a nationally representative study. JCO Precis Oncol. 2021;5:PO.21.00109.
https://doi.org/10.1200/PO.21.00109 DOI: https://doi.org/10.1200/PO.21.00109
Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract. 1997;5(6):361–6.
Dutta S, Biswas N, Muhkherjee G. Evaluation of socio-demographic factors for non-compliance to treatment in locally advanced cases of cancer cervix in a rural medical college hospital in India. Indian J Palliat Care. 2013;19(3):158–65. DOI: https://doi.org/10.4103/0973-1075.121530
Shah M, Parmar A, Chan KKW. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non‐small cell lung cancer 2007–2016. Cancer Med. 2020;9(10):3407–16.
https://doi.org/10.1002/cam4.2978 DOI: https://doi.org/10.1002/cam4.2978
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Nelly-Maria Paakkola, Antti Jekunen, Eero Sihvo, Mikael Johansson, Heidi Andersén
This work is licensed under a Creative Commons Attribution 4.0 International License.
Funding data
-
Turun Yliopistollinen Keskussairaala
Grant numbers 100474
